BioSpace News Archive

Digipath, Inc. (OTCQB: DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that in collaboration with VSSL of Kelowna, BC, has filed a provisional patent application for a Field Testing Kit that can quickly determine whether a plant sample is actually hemp, drug-type THC or drug-type CBD.

Epitomee Medical, a bio-medical company developing treatments for the overweight and obese population, including treatment of glycemic control, weight reduction, and hypertension based on its unique swallowable-device gastric retention platform, announced the closing of an $8 million equity financing led by XT Hi-Tech.

NanoViricides, Inc. a company with novel platform technology to treat difficult and life-threatening viral diseases, reports that US FDA has responded to its request for a pre-IND meeting.

DiscoveryOne™, integrated drug discovery services, provides premier, integrated project management for the pharma and biotech industry.

Strive Clinical Network (Strive), an East Texas network of Primary Care physicians, has produced exceptional first-year results in its care for members of the Employees Retirement System of Texas (ERS).

The NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has awarded a grant to ImmunogenX to conduct a Phase 2 trial for latiglutenase, an investigational drug for celiac disease (CD).

As part of his role at VeraSci, he will assist in the implementation of the trials of both relapsing and progressive forms of multiple sclerosis (MS).

Bravado Health unveils the first core product of its new patient engagement platform with the launch of Ayva Discharge.

Nearly $525,000 in Funds and Health Care Products Donated to Support 12 Pediatric Health Programs

Revance Therapeutics, Inc. announced a pivotal addition to its leadership team with the appointment of Taryn Conway as Vice President, Marketing, effective April 8, 2019.